One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Health Care Disparities, Social Determinants of Health, and Emotional Impacts in Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey
Florence-Damilola Odufalu, MD,*, Marla C. Dubinsky, MD, †Laurent Peyrin-Biroulet, MD, PhD, ‡,*** Karoliina Yl?nne,§ Allyson Sipes,¶ Joseph C. Cappelleri, PhD, MPH,? Leo J. Russo, PhD,** Michelle Segovia, PharmD,**,††, Sean Gardiner, MD,‡‡ Edward P. Johnson,§§ Amy Mulvey,¶¶ and Remo Panaccione, MD
doi : 10.1093/ibd/izad102
Inflammatory Bowel Diseases, Volume 29, Issue 11, November 2023, Pages 1681–1692
Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium
Serre-Yu Wong, MD, PhD,* Judith Wellens, MD,†Drew Helmus, MS,* Luke Marlow, MS,‡ Stephanie Brann, BA,‡ Vicky Martinez Pazos, BA,* Alan Weinberg, MS, § Hunter R. Moran,* Colleen McGregor, MD,‡ Séverine Vermeire, MD,†Kenji Watanabe, MD,¶ Koji Kamikozuru, MD, ¶ Vineet Ahuja, MD,|| Shubi Vermani, MD,|| James O. Lindsay, MD, PhD, ** Ashley Kingston,** Usha Dutta, MD, ††Harmandeep Kaur, MD,††Mark S. Silverberg, MD, ‡‡ Raquel Milgrom, MD, ‡‡ Siew Chien Ng, MD, PhD, §§ Joyce Wing Yan Mak, MD, §§ , Ken Cadwell, PhD,¶¶,||||,*** Craig Thompson, PhD,†††Jean-Frédéric Colombel, MD,* and Jack Satsangi, MD,‡ ICARUS-IBD Consortium
doi : 10.1093/ibd/izad097
Density of Biopsy Sampling Required to Ensure Accurate Histological Assessment of Inflammation in Active Ulcerative Colitis
Russell B. McBride, PhD, MPH,*,# Mayte Suarez-Farinas, PhD, †,# Huaibin M. Ko, MD, ‡ Xiuxu Chen, MD, PhD,§ Qingqing Liu, MD, PhD, ¶ and Noam Harpaz, MD, PhD
doi : 10.1093/ibd/izad063
Impact of Vedolizumab on Extraintestinal Manifestations in Inflammatory Bowel Disease: Results From a Descriptive, Retrospective, Real-world Study
Uri Kopylov, MD,*, Johan Burisch, DMSc, †,‡, Shomron Ben-Horin, MD,* Fiona Braegger, DVM, § Alonso Fern?ndez-Nistal, PhD,¶ Nuria Lara, MD,|| Henriette Sophie Heinrich, PD,**,††and Stephan R. Vavricka, MD
doi : 10.1093/ibd/izad075
Upadacitinib Induction and Maintenance Therapy Improves Abdominal Pain, Bowel Urgency, and Fatigue in Patients With Ulcerative Colitis: A Post Hoc Analysis of Phase 3 Data
Silvio Danese, MD, PhD,*, Jacinda Tran, PharmD,†,‡ Geert D’Haens, MD, PhD,§ David T. Rubin, MD,¶ Nobuo Aoyama, MD,|| Wen Zhou, MD, PhD,‡ Dapo Ilo, MD,‡ Xuan Yao, PhD,‡ Yuri, Sanchez Gonzalez PhD, ‡ and Remo Panaccione, MD
doi : 10.1093/ibd/izad016
Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study
Wei-Chen Lin, MD*,#, , Wei-Chen Tai, MD†,# , Chung-Hsin Chang, MD‡ , Chia-Hung Tu, MD§ , I-Che Feng, MD¶ , Ming-Jium Shieh, MD, PhD|| , Chen-Shuan Chung, MD**, Hsu-Heng Yen, MD††, Jen-Wei Chou, MD ‡‡ , Jau-Min Wong, MD, PhD § , Yu-Hwa Liu, MD§§ , Tien-Yu Huang, MD, PhD¶¶ , Chiao-Hsiung Chuang, MD |||| , Tzung-Jiun Tsai, MD***, Feng-Fan Chiang, MD, PhD †††, Chien-Yu Lu, MD‡‡‡ , Wen-Hung Hsu, MD‡‡‡ , Fang-Jung Yu, MD‡‡‡ , Te-Hsin Chao, MD, PhD §§§ , Deng-Chyang Wu, MD, PhD‡‡‡ , Ai-Sheng Ho, MD¶¶¶ , Hung-Hsin Lin, MD|||||| , Chun-Lung Feng, MD****, Keng-Liang Wu, MD, PhD ††††, Ming-Wun Wong, MD‡‡‡‡ , Chien-Chih Tung, MD §§§§ , Chun-Chi Lin, MD|||||| , Chia-Chang Chen, MD‡ , Huang-Ming Hu, MD‡‡‡,¶¶¶¶ , Lung-Sheng Lu, MD |||||||| , Huann-Sheng Wang, MD*****, I-Chen Wu, MD, PhD ‡‡‡ , Hsin-Yu Kuo, MD†††††,‡‡‡‡‡ , Jia-Feng Wu, MD, PhD §§§§§ , Hsiang Yao Shih, MD‡‡‡ , Yen-Hsuan Ni, MD, PhD ¶¶¶¶¶ , Shu-Lun Tang, PhD|||||||||| , Peng-Hsu Chen, PhD|||||||||| , and Shu-Chen Wei, MD, PhD
doi : 10.1093/ibd/izac269
Real-world Comparative Effectiveness of Ustekinumab vs Anti-TNF in Crohn’s Disease With Propensity Score Adjustment: Induction Phase Results From the Prospective, Observational RUN-CD Study
Bernd Bokemeyer, MD,*,†,‡,#, Sandra Plachta-Danielzik, PhD, ‡,# Romina di Giuseppe, PhD,‡,# Wolfgang Mohl, MD,§ Niels Teich, MD,¶, Martin Hoffstadt, MD,? Axel Schweitzer, MD,** Manfred von der Ohe, MD, ††Annika Gauss, MD,‡‡ Raja Atreya, MD,§§ Thomas Krause, MD, ¶¶ Irina Blumenstein, MD,?? Petra Hartmann,*** and Stefan Schreiber, MD,†; the German Inflammatory Bowel Diseases Study Group (GISG)
doi : 10.1093/ibd/izac271
Sweets and Inflammatory Bowel Disease: Patients Favor Artificial Sweeteners and Diet Foods/Drinks Over Table Sugar and Consume Less Fruits/Vegetables
Abigail Raffner Basson, PhD*,†,‡, , Jeffry Katz, MD†, Sargun Singh, MD*,†, Fabiano Celio, PhD*, Fabio Cominelli, MD*,†,§,¶, , and Alexander Rodriguez-Palacios, PhD, DVM
doi : 10.1093/ibd/izac272
Inflammatory Bowel Disease Among Canadian Children: Comparison Between Children of Non-European Descent and Children of European Descent
Jocelyn Jeong, MD,*,†,‡, Thomas D. Walters, MD, § Hien Q. Huynh, MD,¶ Sally Lawrence, MD,†David R. Mack, MD, || Colette Deslandres, MD,** Anthony Otley, MD,††Wael El-Matary, MD,‡‡, Mary Sherlock, MD,§§ Anne M. Griffiths, MD, § Eytan Wine, MD, PhD, ¶ Kevan Jacobson, MD,†, Peter Church, MD, § Matthew W. Carroll, MD,¶ Eric I. Benchimol, MD, PhD, § Herbert Brill, MD,§§ Jeff Critch, MD,¶¶ Kevin Bax, MD,|||| Prévost Jantchou, MD,** Mohsin Rashid, MD,††, Gilaad G. Kaplan, MD,*,*** Cynthia H. Seow, MD,*,*** Kerri Novak, MD,***, and Jennifer C. deBruyn, MD*,‡ for the Canadian Children IBD Network
doi : 10.1093/ibd/izac276
Histologic Predictors of Clinical Outcomes and Healthcare Utilization in Patients With Ileal Pouch-Anal Anastomosis
Shannon Chang, MD/MBA,*, Simon Hong, MD,* David Hudesman, MD,* Feza Remzi, MD,†Katherine Sun, MD, PhD,‡ Wenqing Cao, MD,‡ H. Tarik Kani, MD,*,§ Jordan Axelrad, MD,*,a, and Suparna A. Sarkar, MD, PhD
doi : 10.1093/ibd/izac277
Deletion of Endogenous Neuregulin-4 Limits Adaptive Immunity During Interleukin-10 Receptor–Neutralizing Colitis
doi : 10.1093/ibd/izad092
A Novel 8-Predictors Signature to Predict Complicated Disease Course in Pediatric-onset Crohn’s Disease: A Population-based Study
Hélène Sarter, MS,*,†Guillaume Savoye, MD, PhD, ‡ Guillemette Marot, PhD,§,¶ Delphine Ley, MD, PhD,†,|| Dominique Turck, MD,†,|| Jean-Pierre Hugot, MD, PhD,**,††Francis Vasseur, MD, PhD,§ Alain Duhamel, PhD,§ Pauline Wils, MD,†,‡‡ Fred Princen, PhD, §§ Jean-Frédéric Colombel, MD, ¶¶ Corinne Gower-Rousseau, MD, PhD,*,†,|||| and Mathurin Fumery, MD, PhD***, ; EPIMAD study group
doi : 10.1093/ibd/izad090
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center
Franco Scaldaferri, PhD,#,*,†Antonio Maria D’Onofrio, MD,#,‡ Rosaria Calia, PhD, #,§,¶ Federica Di Vincenzo, MD,*, Gaspare Filippo Ferrajoli, MD,‡ Valentina Petito, PhD,*, Eleonora Maggio, LM-51, §,¶ Pia Clara Pafundi, PhD, || Daniele Napolitano, RN, MSN,* Letizia Masi, LM-09, * Elisa Schiavoni, RN,* Caterina Fanali, LM-06,* Pierluigi Puca, MD,* Laura Turchini, RN,* Loris Riccardo Lopetuso, PhD,* Federica Del Chierico, PhD,** Lorenza Putignani, PhD, ††Antonio Gasbarrini, PhD, ##,*,†and Giovanni Camardese, PhD
doi : 10.1093/ibd/izad091
Evaluating lleal Pouch Anal Anastomosis Function: Time to Expand Our ARM-amentarium
Yuying Luo, MD,*, Natalia Schmidt, MD, †Marla C. Dubinsky, MD,* Barry Jaffin, MD,* and Maia Kayal, MD, MS
doi : 10.1093/ibd/izac234
Creeping Fat in the Pathogenesis of Crohn’s Disease: An Orchestrator or a Silent Bystander?
Efthymios P. Tsounis, MSc,* Ioanna Aggeletopoulou, PhD,*,†Athanasia Mouzaki, PhD,†and Christos Triantos, PhD
doi : 10.1093/ibd/izad095
Automated Clinical Pathway Utilizing Custom Risk Stratification Identifies Substantial Rates of Overdue Follow-up Among Patients With Inflammatory Bowel Disease and Facilitates Population Health Interventions
Matthew K. Schroeder, MD,*, Sean A. Tan, BA,†Mary-Joe Touma, MD,§ Mujeeb Basit, MD,†,‡ and David I. Fudman, MD
doi : 10.1093/ibd/izad026
Addressing the Risks of Respiratory Syncytial Virus for Patients With Inflammatory Bowel Disease in the Era of Novel Vaccines
Ryan A. Smith, MD,* Aakash Desai, MD,†, Jana G. Hashash, MD, MSc,†Mary S. Hayney, PharmD, MPH,‡ Francis A. Farraye, MD, MSc, †and Freddy Caldera, DO, MS
doi : 10.1093/ibd/izad233
Correction to: Research Progress of Interleukin-27 in Inflammatory Bowel Disease
doi : 10.1093/ibd/izad223
Targeted Probiotics Against Bacterial-Fungal Biofilms: A New Concept Seems to Bring Us Closer to Microbiome-modulating Therapy for Inflammatory Bowel Disease
Stanislav Sitkin, MD, PhD,*,†,‡, and Juris Pokrotnieks, MD, PhD
doi : 10.1093/ibd/izad209
Reply: “Cannabis Use: A Marker of Clinical Severity in Inflammatory Bowel Disease?�
Danny Glickman, BS,* Shannon Dalessio, MA,†Wesley M. Raup-Konsavage, PhD, ‡ Kent E. Vrana, PhD, ‡ and Matthew D. Coates, MD, PhD
doi : 10.1093/ibd/izad222
SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease
Amnuay Kleebayoon, PhD,*, and Viroj Wiwanitkit, MD
doi : 10.1093/ibd/izad230
